The Missoula Chronic Clinical Cannabis Use Study was proposed to investigate the therapeutic bepnefits and adverse effects of prolonged use of "medical marijuana" in a cohort of seriously ill pa- tients. Use of cannabis was approved through the Compassionate Inves- tigational New Drug (IND) program of the Food and Drug Administra- tion (FDA). Cannabis is obtained from the National Institute on Drug